The relationship between Iron and Prostate cancer is somewhat weak. Iron ranks 105 of 950 Prostate cancer treatments we have analyzed.
Prostate cancer also known as carcinoma of the prostate is when cancer develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively fast. The cancer cells may spread from the prostate to other parts of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages it can cause difficulty urinating, blood in the urine, or pain in the pelvis, back or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Other late symptoms may include feeling tired due to low levels of red blood cell.1
Iron is a chemical element with the symbol Fe (from Latin: ferrum) and atomic number 26. It is a metal in the first transition series. It is by mass the most common element on Earth, forming much of Earth's outer and inner core. It is the fourth most common element in the Earth's crust. Its abundance in rocky planets like Earth is due to its abundant production by fusion in high-mass stars, where the production of nickel-56 (which decays to the most common isotope of iron) is the last nuclear fusion reaction that is exothermic. Consequently, radioactive nickel is the last element to be produced before the violent collapse of a supernova scatters precursor radionuclide of iron into space.2
Researchers have concluded:
Iron for Prostate cancer ranks in the bottom 28% of condition-treatment relationships we analyzed.
Importantly, we found only 1 study that was randomized and controlled. Such studies are considered the most rigorous, and help to establish or disprove a cause-and-effect relationship between prospective treatments and conditions. So there may be some good evidence on which to make a decision about using Iron for Prostate cancer.
The relationship between Prostate cancer and Iron has been modestly researched. We found 148 research articles on the topic. This places the volume of research in the bottom 35% of condition-treatment relationships we have analyzed.
Are researchers becoming more or less interested in Iron for Prostate cancer? The pace of research appears to be increasing.
Please note that our analysis is automated and imperfect. If you have personal insight, please help improve our analysis by rating this relationship and the research supporting it. And check back regularly; we last analyzed research for this relationship on August 01, 2014 @9:19PM, and are constantly updating our database and algorithms.